Polyphenols have been employed in the treatment of liver disease, the latter based on the underlying mechanisms implicated principally in improving antioxidant defense enzymes through the mediation of the expression of Nrf-2/cytochrome P450 2E1 (CYP2E1), which improves the inflammatory process. This evidence concerns the gene CYP2E1 and liver disorder.